AGT and renal fibrosis: Similarly, in an angiotensin II (Ang II)-induced mouse hypertensive model, the administration of anti-IL-17A or anti-IL-17RA antibodies reduced blood pressure by 30 mmHg and lowered renal fibrosis, compared to control IgG antibodies.